Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Identifiable Intangible Assets Carrying Value

The net carrying value of the identifiable intangible assets as of December 31, 2019 and December 31, 2018 is as follows:

			As Restated			As Restated
			As of December 31, 2019			As of December 31, 2018
	Life		Carrying			Carrying
	(Years)		Amount			Amount
Asuragen acquisition:
Thyroid		9	$	8,519		$	8,519
RedPath acquisition:
Pancreas test		7		16,141			16,141
Barrett’s test		9		6,719			6,719
BioPharma acquisition:
Trademarks		10		1,600			-
Customer relationships		8		5,700			-
CLIA Lab		2.3	$	609		$	609
Total			$	39,288		$	31,988
Accumulated Amortization			$	(23,439	)	$	(19,450	)
Net Carrying Value			$	15,849		$	12,538

Schedule of Goodwill Carrying Value

The following table displays a roll forward of the carrying amount of goodwill from January 1, 2018 to December 31, 2019:

	Carrying
	Amount
Balance as of January 1, 2018	$	-
Balance as of December 31, 2018		-
Goodwill acquired		8,273
Adjustments		160
Balance as of December 31, 2019	$	8,433

Schedule of Future Estimated Amortization Expense

Amortization expense was approximately $4.0 million and $3.6 million for the years ended December 31, 2019 and 2018, respectively. Estimated amortization expense for the next five years is as follows:

As Restated
2020		2021		2022		2023		2024
$	4,871	$	4,078	$	2,156	$	1,745	$	873